GlassScriptPhysician profile
Taylor B Kirkman
NPI 1740635366
$12,541.39
in general payments reported to CMS, 2019-2025
36 companies · $1,200 in 2025
The $1,200 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $560 · 2020: $963 · 2021: $2,866 · 2022: $2,176 · 2023: $3,291 · 2024: $1,486 · 2025: $1,200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,921 · Travel and Lodging: $2,054 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,920.87 |
| Travel and Lodging | $2,054.29 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,204.87 | 2021-2025 | Amplatzer Amulet, Diamondback Peripheral, Diamondback Coronary |
| Edwards Lifesciences Corporation | $1,990.69 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $1,176.42 | 2019-2025 | Clinical Trial Product, General - Therapies, Eluvia |
| Inari Medical, INC. | $1,074.60 | 2020-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $1,062.56 | 2021-2025 | Micra, Corevalve Evolut R, Linq II |
| Cardiovascular Systems INC. | $935.69 | 2020-2023 | Diamondback Peripheral |
| Abiomed | $627.35 | 2019-2025 | Impella |
| Philips North America LLC | $510.18 | 2023-2025 | Coronary Other |
| Shockwave Medical, INC | $450.62 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $336.62 | 2021-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $268.58 | 2019-2022 | |
| Angiodynamics, INC. | $253.77 | 2021-2025 | Angiovac, Auryon Laser System 100-120 Vac, Angiodynamics |
| Astrazeneca Pharmaceuticals LP | $239.07 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $210.09 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $209.54 | 2023-2025 | Camzyos, Eliquis |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $163.65 | 2023-2025 | |
| Amgen INC. | $119.49 | 2019-2025 | Repatha, Repatha |
| Penumbra, INC. | $113.00 | 2021 | |
| Ekos Corporation | $96.50 | 2019 | |
| Chiesi USA, INC. | $79.02 | 2022 | |
| Merck Sharp & Dohme LLC | $64.02 | 2024-2025 | Verquvo |
| Cordis US Corp. | $44.33 | 2025 | Mynxgrip, Mynx Control |
| Alnylam Pharmaceuticals INC. | $35.26 | 2025 | Amvuttra |
| Irhythm Technologies, INC. | $34.30 | 2023-2024 | Zio Xt Patch |
| Endologix LLC | $29.11 | 2022 | |
| Lantheus Medical Imaging, INC. | $27.45 | 2022 | |
| Vital Connect, INC | $26.58 | 2025 | Vitalpatch Rtm |
| Pfizer INC. | $26.34 | 2025 | |
| Asahi Intecc USA, INC. | $26.23 | 2020 | |
| Terumo Medical Corporation | $21.76 | 2024 | Glidewire, Glidesheath Slender |
| Kiniksa Pharmaceuticals International, Plc | $17.84 | 2024 | Arcalyst |
| Actelion Pharmaceuticals US, INC. | $15.36 | 2023 | Uptravi, Opsumit |
| Scpharmaceuticals INC. | $13.22 | 2024 | |
| Ucb, INC. | $12.90 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.64 | 2019 | |
| Cardiva Medical, INC. | $11.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Kirkman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.